Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 05-2014 | 12-2013 | 05-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 1,670 | N/A | 2,850 |
| Other current assets | 0 | 0 | 470 | 0 | 370 |
| TOTAL | $N/A | $N/A | $2,140 | $N/A | $3,220 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 10 | N/A | 30 |
| TOTAL | $N/A | $N/A | $10 | $N/A | $30 |
| Total Assets | $N/A | $N/A | $2,150 | $N/A | $3,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 180 | 0 | 330 |
| Accrued Expenses | N/A | N/A | 2,040 | N/A | 1,270 |
| TOTAL | $N/A | $N/A | $3,050 | $N/A | $1,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 140 | N/A | 0 |
| Other Non-Current Liabilities | 0 | 0 | 480 | 0 | 0 |
| TOTAL | $N/A | $N/A | $620 | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $3,680 | $N/A | $1,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 693 | N/A | 8 | N/A |
| Common Shares | N/A | N/A | 170,180 | N/A | 176,750 |
| Retained earnings | N/A | N/A | -196,090 | N/A | -199,790 |
| Other shareholders' equity | 0 | 0 | 3,930 | 0 | 3,210 |
| TOTAL | $N/A | $N/A | $-1,520 | $N/A | $1,650 |
| Total Liabilities And Equity | $0 | $0 | $2,160 | $0 | $3,250 |